Taurine
CAS 107-35-7
Taurine (CAS 107-35-7) is a Phase 3 pharmaceutical compound with 7 bioactivity targets and 144 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | GI50 | 100000 nM | 54 | - |
| - | Potency | 15562.54347826087 nM | 22 | - |
| - | IC50 | 36.666666666666664 ug.mL-1 | 3 | - |
| - | AC50 | 4771.75 nM | 2 | - |
| - | IC50 | 19976.309999999998 nM | 1 | - |
| - | EC50 | 10000 nM | 1 | - |
| - | MIC | 100 ug.mL-1 | 1 | - |
Adverse Event Associations
DrugCentral / FAERS disproportionality signal rows matched to this compound.
| Reaction PT | Drug AE | LLR | MedDRA |
|---|---|---|---|
| Retinogram abnormal | 7 | 44.029 | 10059663 |
Association rows are source-linked signal records, not incidence rates or clinical causality claims.
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| Glycine Receptor (All subtypes) | Agonist | 3.84 pEC50 | 9009272 |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| TAURINE | 10337 | SU | MTHSPL |
| taurine | 10337 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Taurine used for in pharmaceutical contexts?
Taurine (CAS 107-35-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Taurine?
Taurine has 144 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Retinogram abnormal, Abdominal pain, Abdominal pain upper, Allergy to animal, Amylase increased. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Taurine also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Taurine with EU status "permitted".
What clinical phase is Taurine in?
Taurine is rendered with ChEMBL max phase 3.